Artificial Intelligence in Medicine
Volume 43, Issue 3 , Pages 207-222 , July 2008

Ovarian cancer diagnosis with complementary learning fuzzy neural network

  • Tuan Zea Tan

      Affiliations

    • Centre for Computational Intelligence, School of Computer Engineering, Nanyang Technological University, Block N4, #2A-32, Nanyang Avenue, Singapore 639798, Singapore
    • ,
  • Chai Quek

      Affiliations

    • Centre for Computational Intelligence, School of Computer Engineering, Nanyang Technological University, Block N4, #2A-32, Nanyang Avenue, Singapore 639798, Singapore
    • Corresponding Author InformationCorresponding author. Tel.: +65 6790 4926; fax: +65 6790 6559.
    • ,
  • Geok See Ng

      Affiliations

    • Centre for Computational Intelligence, School of Computer Engineering, Nanyang Technological University, Block N4, #2A-32, Nanyang Avenue, Singapore 639798, Singapore
    • ,
  • Khalil Razvi

      Affiliations

    • Department of Obstetric and Gynaecology, Southend University Hospital NHS Foundation Trust, Prittlewell Chase, Westcliff-on-Sea, Essex SS0 0RY, UK

Received 22 November 2006 ,Revised 15 April 2008 ,Accepted 15 April 2008.

References 

  1. American Cancer Society . Cancer facts and figures. US: American Cancer Society; 2007;
  2. Jermal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistic 2003. CA: Cancer Journal for Clinician. 2003;13:5–26
  3. NIH, NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up, NIH Consensus Developmental Panel on Ovarian Cancer. Journal of the American Medical Association 1995;273(6):491–7.
  4. Petignat P, Joris F, Faltin D. Importance of the general practitioner in the early detection of ovarian cancer. Gynecologic Oncology. 2003;90:491–500
  5. Kurtz AB, Tsimikas JV, Tempany CMC, Hamper UM, Arger PH, Bree RL, et al. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis—report of the radiology diagnostic oncology group. Radiology. 1999;212:19–27
  6. US Preventive Services Task Force . Guide to preventive services. 2nd ed.. Washington, DC: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion; 1996;
  7. Fiorica JV, Roberts WS. Screening for ovarian cancer. Cancer Control. 1996;3(2):120–129
  8. Low RN, Saleh F, Song SYT, Shiftan TA, Barone RM, Lacey CG, et al. Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination—a longitudinal study. Radiology. 1999;211:519–528
  9. Guerriero S, Alcazar JL, Ajossa S, Lai MP, Errasti T, Mallarini G, et al. Comparison of conventional color Doppler imaging and power Doppler imaging for the diagnosis of ovarian cancer: results of a European study. Gynecologic Oncology. 2001;83:299–304
  10. Jeong Y, Outwater EK, Kang HK. Imaging evaluation of ovarian masses. Radiographics. 2000;20:1445–1470
  11. Kusnetzoff D, Gnochi D, Damonte C, Sananes C, Giaroli A, di Paolo G, et al. Differential diagnosis of pelvic masses: usefulness of CA125, transvaginal sonography and echo-Doppler. International Journal of Gynecology Cancer. 1998;8(4):315–321
  12. Loyer EM, Whitman GJ, Fenstermacher MJ. Imaging of ovarian carcinoma. International Journal of Gynecology Cancer. 1999;9:351–361
  13. Cohen LS, Escobar PF, Scharm C, Glimco B, Fishman DA. Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction. Gynecologic Oncology. 2001;82:40–48
  14. Kurjak A, Kupesic S, Sparac V, Prka M, Bekavac I. The detection of stage I ovarian cancer by three-dimensional sonography and power Doppler. Gynecologic Oncology. 2003;90:258–264
  15. Shaharabany Y, Akselrod S, Tepper R. A sensitive new indicator for diagnostics of ovarian malignancy, based on the Doppler velocity spectrum. Ultrasound in Medicine & Biology. 2004;30(3):295–302
  16. Tailor A, Jurkovic D, Bourne TH, Natucci M, Collins WP, Campbell S. A comparison of intratumoural indices of blood flow velocity and impedance for the diagnosis of ovarian cancer. Ultrasound in Medicine and Biology. 1996;22(7):837–843
  17. Low RN, Carter WD, Saleh F, Sigeti JS. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, in-111-CYT-103 immunoscintigraphy and CT. Radiology. 1995;195:391–400
  18. Makhija S, Howden N, Edwards R, Kelley J, Townsend DW, Meltzer CC. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecologic Oncology. 2002;85:53–58
  19. Pannu HK, Cohade C, Bristow RE, Fishman EK, Wahl RL. PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation. Abdominal Imaging. 2004;39:398–403
  20. Fultz PJ, Jacobs CV, Hall WJ, Gottlieb R, Rubens D, Totterman SMS, et al. Ovarian cancer: comparison of observer performance for four methods of interpreting CT scans. Radiology. 1999;212:401–410
  21. Lapchenkov VI, Dudarev AL, Vinokurov VL, Yurkova LE, Barbanel EIu. Comparative evaluation of diagnostic significance of carbohydrate antigen CA125 and cancer-embryonal antigen in ovarian cancer. Vestnik Rentgenologii I Radiologii. 1993;5:30–31(in Russian)
  22. Timmerman D. Ultrasonography in the assessment of ovarian and tamoxifen-associated endometrial pathology. PhD dissertation. Leuven University Press; 1997.
  23. Zhang Z, Zhang H, Bast RC. An application of artificial neural networks in ovarian cancer early detection. In:  Amari S-I,  Lee Giles C,  Gori M,  Piuri V editor. Proceedings of the IEEE international joint conference on neural networks, vol. 4. US: The Institute of Electrical and Electronics Engineers, Inc.; 2000;p. 107–112
  24. Runowicz CD. Ovarian cancer screening. American College of Medical Genetic Foundation, Genetic susceptibility to breast and ovarian cancer: assessment, counseling and testing guidelines. New York State Department of Health; 1999;
  25. Sliutz G, Tempfer C, Kainz C, Mustafa G, Gitsch G, Koelbl H, et al. Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer. Anticancer Research. 1995;15(3):1127–1129
  26. Bozkurt N, Yuce K, Basaran M, Kose F, Ayhan A. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer. Obstetric Gynecology. 2004;103(1):82–85
  27. Wen W, Bernstein L, Lescallett J, Beazer-Barclay Y, Sullivan-Halley J, White M, et al. Comparison of TP53 mutations identified by oligonucleotide micro-array and conventional DNA sequence analysis. Cancer Research. 2000;60:2716–2722
  28. The University of Iowa's Cancer Center . Tumour marker tests. University of Iowa; 2002;available http://www.vh.org/adult/patient/cancercenter/tumormarker [accessed June 20, 2006]
  29. Yang ST. Micro-array application in medicine. 2002;available http://binfo.ym.edu.tw/styang/seminar/medicine/array_medicine.htm [accessed June 20, 2006]
  30. Kohn EC, Mills GB, Liotta L. Promising directions for the diagnosis and management of gynecological cancers. International Journal of Gynaecology Obstetric. 2003;83(Suppl 1):203–209
  31. Antal P, Verrelst H, Timmerman D, Moreau Y, Van Huffel S, De Moor B, et al. Bayesian networks in ovarian cancer diagnosis: potentials and limitations. In: Proceedings of 13th IEEE on computer-based medical systems. US: The Institute of Electricals and Electronics Engineers, Inc.; 2000;p. 103–108
  32. Odusanya AA. Ovarian cancer prognosis and soft computing. In:  Clark JW,  McIntire LV,  Ktonas PY,  Mikos AG,  Ghorbel FH editor. Proceedings of the second joint EMBS/BMES conference, vol. 1. US: The Institute of Electricals and Electronics Engineers, Inc.; 2002;p. 60–61
  33. Snow PB, Brandt JM, Larry Williams R. Neural network analysis of the prediction of cancer recurrence following debulking laparotomy and chemotherapy in Stages III and IV ovarian cancer. Molecular Urology. 2001;5(4):171–174
  34. Renz C, Rajapakse JC, Razvi K, Liang SKC. Ovarian cancer classification with missing data. In:  Wang L,  Rajapakse JC,  Fukushima K,  Lee SY,  Yao X editor. Proceedings of the ninth international conference on neural information processing, vol. 2. US: The Institute of Electricals and Electronics Engineers, Inc.; 2002;p. 809–813
  35. Antal P, Fannes G, Timmerman D, Moreau Y, De Moor B. Using literature and data to learn Bayesian networks as clinical models of ovarian tumors. Artificial Intelligence in Medicine. 2004;30:257–281
  36. Wallace JC, Raaphorst GP, Somorjai RL, Ng CE, Fung FK, Senterman M, et al. Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis. Magnetic Resonance in Medicine. 1997;38(4):569–576
  37. Kusy M. Application of SVM to ovarian cancer classification problem. In: Rutkowski L, et al., editors. Proceedings of the international conference on artificial intelligence and soft computing. Lecture Notes in Artificial Intelligence 3070. Berlin, Heidelberg: Springer-Verlag; 2004. p. 1020–25.
  38. Ben-Dor A, Bruhn L, Friedman N, Nachman I, Schummer M, Yakhini Z. Tissue classification with gene expression profiles. In:  Shamir R,  Miyano S,  Istrail S,  Pevzner P,  Waterman M editor. Proceedings of the fourth annual international conference on computational molecular biology. New York: ACM; 2000;p. 54–64
  39. Loo L, Quinn J, Cordingley H, Roberts S, Hrebien L, Kam M. Classification of SELDI-ToF mass spectra of ovarian cancer serum samples using a proteomic pattern recognizer. In:  Reisman S,  Foulds R,  Mantilla B editor. Proceedings of IEEE 29th annual bioengineering conference. US: The Institute of Electricals and Electronics Engineers, Inc.; 2003;p. 130–131
  40. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359:572–577
  41. Stevens EV, Liotta LA, Kohn EC. Proteomic analysis for early detection of ovarian cancer: a realistic approach?. International Journal of Gynecology Cancer. 2003;13(Suppl 2):133–139
  42. Tan TZ, Quek C, Ng GS, Ng EYK. A novel cognitive interpretation of breast cancer thermography with complementary learning fuzzy neural memory structure. Expert Systems with Applications. 2007;33(3):652–666
  43. Tan TZ, Quek C, Ng GS. Ovarian cancer diagnosis by hippocampus and neocortex-inspired learning memory structures. Neural Networks. 2005;18(5/6):818–825
  44. Schummer M, Ng W, Bumgarner R, Nelson P, Schummer B, Bednarski D, et al. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery genes over-expressed in ovarian carcinomas. Gene. 1999;238:375–385
  45. Witten I, Frank E. Data mining: practical machine learning tools and techniques. 2nd ed.. San Francisco: Morgan Kaufmann; 2005;
  46. Jang JSR. ANFIS: adaptive network based fuzzy inference systems. IEEE Transactions on System, Man and Cybernetics. 1993;23(3):665–685
  47. Shevade SK, Keerthi SS. A simple and efficient algorithm for gene selection using sparse logistic regression. Technical report. CD-02-22, Control Division, Department of Mechanical Engineering, National University of Singapore, Singapore; 2002. p. 117–576.
  48. Liu H, Li J, Wong L. A comparative study on feature selection and classification methods using gene expression profiles and proteomic patterns. Genomic Informatics. 2002;13:51–60
  49. Timm H, Döring C, Kruse R. Different approaches to fuzzy clustering of incomplete datasets. International Journal of Approximate Reasoning. 2004;35:239–249
  50. Van Cott EM, Laposata M. Coagulation. In:  Jacobs DS, et al. editor. The laboratory test handbook. 5th ed.. Cleveland: Lexi-Comp; 2001;p. 327–358
  51. Hoek JA, Sturk A, ten Cate JW, Lamping RJ, Berends F, Borm JJ. Laboratory and clinical evaluation of an assay of thrombin–antithrombin III complexes in plasma. Clinical Chemistry. 1988;34:2058–2062
  52. Quah KH, Quek C. MCES: a novel Monte Carlo evaluative selection approach for objective feature selections. IEEE Transactions on Neural Networks. 2007;18(2):431–448
  53. Al-Nafussi A. Ovarian epithelial tumours: common problems in diagnosis. Current Diagnostic Pathology. 2004;10:473–499
  54. Zhang Z, Liu Y, Zhao T. SVM based feature screening applied to hierarchical cervical cancer detection. In: Proceedings of the international conference on diagnostic imaging and analysis. 2002;p. 393–398
  55. Casillas J, Cordón O, Herrera F. Interpretability improvements to find the balance interpretability—accuracy in fuzzy modeling: an overview. In:  Casillas J,  Cordón O,  Herrera F,  Magdalena L editor. Accuracy improvements in linguistic fuzzy modeling, Studies in fuzziness and soft computing. Heidelberg: Springer-Verlag; 2003;p. 27–45
  56. C2I, Centre for Computational Intelligence, http://www.c2i.ntu.edu.sg/; accessed November 28, 2007.
  57. Ang KK, Quek C. RSPOP: rough set-based pseudo-outer-product fuzzy rule identification algorithm. Neural Computation. 2005;17(1):205–243
  58. Liu F, Quek C, Ng GS. A novel generic Hebbian ordering-based fuzzy rule reduction approach to mamdani neuro-fuzzy system. Neural Computation. 2007;19(6):1656–1680
  59. Tan TZ, Quek C, Ng GS. Biological brain-inspired genetic complementary learning for stock market and bank failure prediction. Computational Intelligence. 2007;23(2):236–261
  60. Tan TZ, Ng GS, Quek C, Koh SCL. Ovarian cancer prognosis by hemostasis and complementary learning. Neural Information Processing, PT 3, Proceedings. Lecture Notes in Computer Science. 2006;4234:145–154
  61. Tung WL, Quek C. FALCON: fuzzy neural control and decision systems using FKP and PFKP clustering algorithms. IEEE Transactions on Systems, Man and Cybernetics, Part B. 2004;34(1):686–694
  62. Quek C, Tung WL. A novel approach to fuzzy membership functions using the FALCON-MART architecture. Pattern Recognition Letters. 2001;22(9):941–958
  63. Tan TZ, Ng GS, Quek C. A novel biologically and psychologically inspired fuzzy decision support system: hierarchical complementary learning. IEEE Transactions on Computational Biology and Bioinformatics. 2008;5(1):67–79
  64. Tan TZ, Quek C, Ng GS. Chance discovery using complementary learning fuzzy neural network. Studies in Computational Intelligence. 2006;30:117–134

PII: S0933-3657(08)00042-0

doi: 10.1016/j.artmed.2008.04.003

Artificial Intelligence in Medicine
Volume 43, Issue 3 , Pages 207-222 , July 2008

Article Tools

* Image Usage & Resolution